 |
|
allogeneic CD4+ memory Th1-like T cells/microparticle-bound anti-CD3/anti-CD28
A preparation consisting of allogeneic, differentiated Th1-like T cells bound to T cell-stimulating monoclonal antibodies with potential antitumor activity. More specifically, allogeneic CD4+ memory Th1-like T cells/microparticle-bound anti-CD3/anti-CD28 are composed of a proprietary preparation of mismatched, allogeneic differentiated CD4+ memory Th1-like T cells bound to paramagnetic, epoxy-covered 4.5 micron microparticles with covalently bound anti-CD3/anti-CD28 monoclonal antibodies at a 2:1 bead:cell ratio. The CD4+ memory Th1-like T cells are derived from precursors found in the circulation of a normal donor. Stimulated by the microparticle-bound monoclonal antibodies, the infused T cells produce pro-inflammatory, anti-tumor cytokines such as like IFN-gamma, TNF-beta, and IL-2, disabling tumor immune avoidance mechanisms and stimulating the host immune system to both reject the infused T cells and kill tumor cells. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Foreign brand name: | | AlloStim | | |
| Previous: | alfuzosin hydrochloride, ALIMTA, alitretinoin, Alkeran, allogeneic B7.1/HLA-A1 transfected tumor cell vaccine | | Next: | allogeneic dendritic cell-myeloma idiotype vaccine, allogeneic GM-CSF-secreting breast cancer vaccine, allogeneic large multivalent immunogen melanoma vaccine LP2307, allogeneic LMP1-/LMP2- specific cytotoxic T-lymphocytes, allogeneic melanoma vaccine AGI-101H |
|
|
